In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Zilbermint highlights Lantus (insulin glargine ... U.S. sales of the FlexPen version of Levemir in April 2024 and Levemir vials by the end of December. While other insulins are available, you ...
The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine ... prices of the originator insulin are around $329 per vial and $510 for five pens, according to ...
During his 2023 State of the State tour, Newsom announced California would begin selling insulin for $30 a vial with a “2024 ...
28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% insulin aspart protamine suspension ...